Does SACITUZUMAB GOVITECAN Cause Myelosuppression? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Myelosuppression have been filed in association with SACITUZUMAB GOVITECAN (TRODELVY). This represents 0.8% of all adverse event reports for SACITUZUMAB GOVITECAN.
10
Reports of Myelosuppression with SACITUZUMAB GOVITECAN
0.8%
of all SACITUZUMAB GOVITECAN reports
1
Deaths
5
Hospitalizations
How Dangerous Is Myelosuppression From SACITUZUMAB GOVITECAN?
Of the 10 reports, 1 (10.0%) resulted in death, 5 (50.0%) required hospitalization, and 4 (40.0%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SACITUZUMAB GOVITECAN. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does SACITUZUMAB GOVITECAN Cause?
Disease progression (389)
Diarrhoea (184)
Death (182)
Inappropriate schedule of product administration (147)
Neutropenia (128)
Off label use (111)
Fatigue (109)
Febrile neutropenia (92)
Asthenia (90)
Weight decreased (89)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which SACITUZUMAB GOVITECAN Alternatives Have Lower Myelosuppression Risk?
SACITUZUMAB GOVITECAN vs SACITUZUMAB GOVITECAN-HZIY
SACITUZUMAB GOVITECAN vs SACROSIDASE
SACITUZUMAB GOVITECAN vs SACUBITRIL
SACITUZUMAB GOVITECAN vs SACUBITRIL\VALSARTAN
SACITUZUMAB GOVITECAN vs SAFINAMIDE